Nuclear hypertrophy reflects increased biosynthetic activities in myocytes of human hypertrophic hearts

被引:30
作者
Koda, Masahiko
Takemura, Genzou
Okada, Hideshi
Kanoh, Motoo
Maruyama, Rumi
Esaki, Masayasu
Li, Yiwen
Miyata, Shusaku
Kanamori, Hiromitsu
Li, Longhu
Ogino, Atsushi
Kondo, Takehito
Minatoguchi, Shinya
Fujiwara, Takako
Fujiwara, Hisayoshi [1 ]
机构
[1] Gifu Univ, Sch Med, Dept Internal Med 2, Gifu 500, Japan
[2] Kyoto Womens Univ, Dept Food Sci, Kyoto, Japan
关键词
biosynthesis; cardiac hypertrophy; cardiomyopathy; heart failure; ultrastructure;
D O I
10.1253/circj.70.710
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The nucleus of the myocytes in human hypertrophic hearts is characterized by its bizarre shape and widespread clumping of chromatin. The functional significance has not been determined. Methods and Results Left ventricular (LV) endomyocardial biopsies obtained from patients with dilated cardiomyopathy (DCM, n = 23), postmyocarditis (n = 13), hypertrophic cardiomyopathy (HCM, n = 21), apical hypertrophic cardiornyopathy (APH, n = 11) and hypertensive heart disease (HHD, n = 11), and from nonhypertrophic hearts (controls, n = 14) were examined. Myocyte size and LV mass index were similar among the hypertrophic hearts, but the nuclear hypertrophy score (grade 0-3) was highest in hearts with systolic failure (DCM and postmyocarditis) and higher in those without it (HCM, APH, and HHD), compared with controls. So were biosynthetic activities such as DNA repair/synthesis, immunohistochemically assessed by proliferating cell nuclear antigen, transcription activity by spliceosome component of 35kDa, and translation efficiency by 70kDa S6 protein kinase. There were significant correlations between nuclear hypertrophy and each biosynthetic activity. Additionally, most of the proliferating cell nuclear antigen-positive nuclei co-expressed oxidative DNA damage markers. Conclusion A link is suggested between structural alteration and molecular biological events in the nuclei of myocytes from human hypertrophic hearts; the nuclear hypertrophy reflects increased biosynthetic activities of DNA repair/synthesis, transcription, and translation efficiency.
引用
收藏
页码:710 / 718
页数:9
相关论文
共 30 条
[11]   Regulation of ribosomal DNA transcription during contraction-induced hypertrophy of neonatal cardiomyocytes [J].
Hannan, RD ;
Luyken, J ;
Rothblum, LI .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (06) :3213-3220
[12]   PROTOONCOGENE INDUCTION AND REPROGRAMMING OF CARDIAC GENE-EXPRESSION PRODUCED BY PRESSURE OVERLOAD [J].
IZUMO, S ;
NADALGINARD, B ;
MAHDAVI, V .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (02) :339-343
[13]   Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy - Not apoptosis but DNA repair [J].
Kanoh, M ;
Takemura, G ;
Misao, J ;
Hayakawa, Y ;
Aoyama, T ;
Nishigaki, K ;
Noda, T ;
Fujiwara, T ;
Fukuda, K ;
Minatoguchi, S ;
Fujiwara, H .
CIRCULATION, 1999, 99 (21) :2757-2764
[14]   Apoptotic versus autophagic cell death in heart failure [J].
Knaapen, MWM ;
Davies, MJ ;
De Bie, M ;
Haven, AJ ;
Martinet, W ;
Kockx, MM .
CARDIOVASCULAR RESEARCH, 2001, 51 (02) :304-312
[15]  
KOMURO I, 1993, ANNU REV PHYSIOL, V55, P55, DOI 10.1146/annurev.physiol.55.1.55
[16]   DIAGNOSTIC AND PROGNOSTIC VALUE OF ENDOMYOCARDIAL BIOPSY IN PATIENTS WITH CONGESTIVE CARDIOMYOPATHY [J].
KUHN, H ;
BREITHARDT, G ;
KNIERIEM, HJ ;
LOOGEN, F ;
BOTH, A ;
SCHMIDT, WAK ;
STROOBANDT, R ;
GLEICHMANN, U .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1975, 100 (14) :717-&
[17]   PROGNOSIS AND POSSIBLE PRESYMPTOMATIC MANIFESTATIONS OF CONGESTIVE CARDIOMYOPATHY (COCM) [J].
KUHN, H ;
KNIERIEM, HJ ;
LOSSE, B ;
BREITHARDT, G ;
KOHLER, E ;
SEIPEL, L ;
LOOGEN, F .
POSTGRADUATE MEDICAL JOURNAL, 1978, 54 (633) :451-461
[18]  
MARON BJ, 1975, AM J PATHOL, V79, P387
[19]   MYOCARDIUM - STRUCTURAL AND ULTRASTRUCTURAL BASIS OF MYOCARDIAL-DISEASE [J].
OLSEN, EGJ .
PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE-LONDON, 1976, 69 (03) :195-197
[20]   Report of the 1995 World Health Organization International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies [J].
Richardson, P ;
McKenna, W ;
Bristow, M ;
Maisch, B ;
Mautner, B ;
OConnell, J ;
Olsen, E ;
Thiene, G ;
Goodwin, J ;
Gyarfas, I ;
Martin, I ;
Nordet, P .
CIRCULATION, 1996, 93 (05) :841-842